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Abstract
Age-related decline in the integrity of mitochondria is an important contributor to the human ageing process. In a number
of ageing stem cell populations, this decline in mitochondrial function is due to clonal expansion of individual mitochondrial
DNA (mtDNA) point mutations within single cells. However the dynamics of this process and when these mtDNA mutations
occur initially are poorly understood. Using human colorectal epithelium as an exemplar tissue with a well-defined stem cell
population, we analysed samples from 207 healthy participants aged 17–78 years using a combination of techniques
(Random Mutation Capture, Next Generation Sequencing and mitochondrial enzyme histochemistry), and show that: 1)
non-pathogenic mtDNA mutations are present from early embryogenesis or may be transmitted through the germline,
whereas pathogenic mtDNA mutations are detected in the somatic cells, providing evidence for purifying selection in
humans, 2) pathogenic mtDNA mutations are present from early adulthood (,20 years of age), at both low levels and as
clonal expansions, 3) low level mtDNA mutation frequency does not change significantly with age, suggesting that mtDNA
mutation rate does not increase significantly with age, and 4) clonally expanded mtDNA mutations increase dramatically
with age. These data confirm that clonal expansion of mtDNA mutations, some of which are generated very early in life, is
the major driving force behind the mitochondrial dysfunction associated with ageing of the human colorectal epithelium.
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Introduction
Mutations of mitochondrial DNA (mtDNA) have been impli-
cated in the ageing process [1]. As humans age, multiple different
mutations arise somatically in individual cells and some of these
expand clonally to high levels over time, resulting in focal
respiratory chain deficiencies [2–6]. To date there is poor
understanding of the dynamics of mutation accumulation during
ageing and of when in the life-course the majority of these clonally
expanded somatic mtDNA mutations initially occur [7]. For
example, there have been suggestions that the underlying
mechanism involves either an accelerating mtDNA mutation rate
over time [8], or clonal expansion of mtDNA mutations which
have occurred in early life [7].
Resolving these questions about the dynamics of mtDNA point
mutations is important because of their accumulation in human
stem cell populations with age, which results in respiratory chain
dysfunction [5,9–14] and consequent reductions in cell function
[15]. Age-related dysfunction of somatic stem cells has been
proposed to lead to the decreased ability of tissues to regenerate
[16]. Mice with increased mtDNA mutagenesis (mutator mice)
caused by a defect in the proof-reading ability of the mitochondrial
DNA polymerase gamma also show a premature ageing pheno-
type [17,18] which has been attributed largely to somatic stem cell
dysfunction resulting from high mtDNA point mutation loads
[19–22]. In mutator mice the majority of the mutational burden
leading to a cellular phenotype occurs during embryogenesis [19].
However, in human tissues there have been no comprehensive
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studies examining mtDNA point mutation occurrence and
accumulation over the life-course.
Here, we apply different validated techniques to investigate the
frequency of both low level (as an indirect measure of mutation
rate) and clonally expanded mtDNA mutations, using the human
colonic epithelium as an exemplar tissue with a well-characterised
stem cell population. We found no evidence of a significant
increase in the frequency of low level mtDNA mutations with age,
but there was a significant increase in the frequency of clonally
expanded mtDNA mutations with age. We provide robust
evidence that mtDNA mutations occur early in life and that a
substantial mtDNA point mutation burden exists within the
human colorectal epithelium before the age of 20.
Results
No significant increase in low level mtDNA mutation
frequency with age
Colorectal biopsies from 207 subjects aged 17–78 years with no
evidence of bowel pathology at endoscopy were collected. Low
level mtDNA mutation frequencies were quantified in these biopsy
samples using a highly sensitive Random Mutation Capture
(RMC) assay [23,24] (Figure 1A). Approximately 200 million base
pairs of mtDNA sequence were screened and a total of 803
mutations were detected. All mutations and full details of the
number of bases investigated per individual are shown in Table
S1. Examination of the types of mutational events detected by
RMC in our cohort showed that 60% of all mtDNA mutations
were G.A or C.T transitions, 24% were T.C or A.G
transitions, and the remainder were transversions and small
insertions and deletions. We also noted an uneven distribution of
mutations across the four base pair TCGA TaqIa site; 63% of
changes were at the third base pair, with the remaining 37%
spread fairly evenly across the other 3 bases. There was no
significant correlation between low level mtDNA mutation fre-
quency and age (Pearson correlation= 0.127 (p = 0.07, Figures 1B
and 1C)). The RMC assay can be intrinsically noisy due to
random sampling statistics [25], with inter-individual variation
often observed in studies of ageing populations [26]. Therefore to
maximise our chance of detecting a relationship between low level
mtDNA mutation frequency and age, we pooled the data by
decade of participant age. Although there was a modest increase in
low-level mutation frequency with age (Figure 1D), this was not
statistically significant (p = 0.343, One Way ANOVA). A Tukey
post-hoc comparison revealed no significant differences even for
the comparison between the first and the last decade of participant
age. In a number of subjects we were not able to detect any
mtDNA mutations in the base pairs screened. To ensure that these
zero values were not having a significant effect on the data we re-
ran the analyses excluding the zero values. There was still no
significant association with age in either the individual data points
(p=0.07, Pearson correlation=0.136) or the grouped data (p=0.46,
One Way ANOVA) (Figure S1). These data highlight that even the
youngest person studied (aged 17 years) had an appreciable mtDNA
mutation frequency of 2.5 mutations per 106 base pairs. Collectively
these analyses demonstrate no significant increase in low level
mtDNA mutation frequency with age. There was no significant
difference in the frequency of synonymous and non-synonymous
mtDNA mutations in older (.46 years) vs younger participants (,46
years) (p= 0.665, Fisher’s exact test). This confirms that there are no
selective pressures acting on mtDNA point mutation occurrence with
age and that mtDNA mutations present from early adulthood in the
human colon could be pathogenic later in life if they were to clonally
expand to high levels over time.
Significant increase in the frequency of clonal expansions
and low level heteroplasmic mtDNA mutations with age
Due to the small size of the region of the genome under
investigation by the RMC assay, and the relative rarity of clonally
expanded mutations across the entire mtDNA molecule, the RMC
will not detect most of the clonally expanded mtDNA mutations.
Indeed, in our RMC mutation dataset there were no mutations
expanded to more than the equivalent of 1/100 of a crypt size.
Therefore, we employed a next generation sequencing (NGS)
approach to examine all mtDNA sites and gain information about
the age dependent dynamics of clonally expanded mutations.
Whole mtDNA Ion Torrent NGS was carried out on DNA
extracted from the biopsies from a representative subset of the
youngest (,26 years of age n= 8) and oldest participants (.70
years of age, n= 8) investigated by RMC. Our stringent quality
control criteria (see Materials and Methods) set the heteroplasmy
threshold for calling mtDNA mutations at 0.8%. Based on this
figure and the average number of crypts per biopsy (,200), our
NGS assay could detect homoplasmic clonal expansions within
individual crypts or clusters of clonal crypts [14], as well as low
levels of heteroplasmic mtDNA mutations (.0.8%) present
throughout the whole tissue [27,28]. Figure 2 details the various
techniques employed throughout the study and the limits of
detection for each technique.
We sequenced a total of 556 Mb of mtDNA (average of 35 Mb
per subject) and detected 109 mutations present at .0.8%
heteroplasmy. All detected mtDNA variants are detailed in Table
S2. All participants showed some variants at.0.8% heteroplasmy,
but the frequency of mtDNA mutations was more than 8-fold
higher in the older than in the younger group (Figure 3A,
p= 0.036, unpaired t-test). There was no significant difference in
the types (transitions/transversions) of mutations observed between
the two age groups (Figure 3B, p= 1.00, Fisher’s exact test), with
single nucleotide transitions being by far the major mutation type.
A recent study has shown that recurrent tissue-specific mtDNA
mutations are present in unrelated individuals [29]. We investi-
gated our NGS data to determine whether recurrent mtDNA
mutations were also present within our dataset. In our colon data
we detected eight unique mtDNA mutations that were present in
Author Summary
Mitochondrial DNA (mtDNA) mutations have been shown
to accumulate with age in a number of human stem cell
populations and cause mitochondrial dysfunction within
individual cells resulting in a cellular energy deficit. The
dynamics by which mtDNA mutations occur and accumu-
late within individual cells (known as clonal expansion) is
poorly understood. In particular we do not know when in
the life-course these mtDNA mutations occur. Here we
have measured mtDNA mutation frequency using three
different techniques; Random Mutation Capture, which
measures low level mutation frequency as an indirect
measure of mutation rate, Next Generation Sequencing,
which measures clonally expanded mtDNA mutation
frequency, and mitochondrial enzyme histochemistry as a
marker of clonally expanded mtDNA mutations, on
colorectal mucosal biopsies obtained from 207 healthy
participants aged 17–78 years. We show that, by 17 years
of age, there is a substantial mtDNA point mutation
burden and that clonal expansion of early to mid-life
mtDNA mutations is likely to be the cause of mitochondrial
dysfunction associated with ageing in the human colon.
Clonal Expansion of Early-Life mtDNA Mutations in Ageing Human Colon
PLOS Genetics | www.plosgenetics.org 2 September 2014 | Volume 10 | Issue 9 | e1004620
two individuals; however unlike the data from Samuels et al, they
were not restricted to the non-coding regions, but appeared to be
located randomly; three were in the non-coding region, three were
in protein encoding genes and two were in RNA genes. Five of
these were previously reported polymorphic variants [30], the
remaining three were previously unreported. There is no evidence
of contamination as they do not fit a haplogroup specific pattern
with multiple markers seen in individual subjects [31], they were
present in random pairs of subjects, and they were not observed in
the yeast plasmid control.
Exclusion of low level inherited heteroplasmic mtDNA
mutations
It has recently been shown that mtDNA mutations in adult
tissues can originate in embryonic development or even in the
germline [27,28], inferring that some of the mutations that we
detected by NGS could have occurred during this period. To
investigate this possibility, matched buccal scrape samples were
collected at the same time as the colorectal mucosal biopsies from
the same 16 participants from whom we had carried out NGS
(data in Figure 3), and NGS was performed on DNA from the
buccal cells. Identification of the same mtDNA mutations in two
different tissues would support the hypothesis that such mutations
occurred prior to tissue differentiation during embryogenesis. It
should be noted that buccal and colonic epithelial cells both arise
from the endoderm with the fore and hind gut becoming separate
tissues by weeks 3–4 of gestation [32]. In DNA from the 16
participants investigated, we detected a total of 16 mtDNA
mutations that were present at low levels of heteroplasmy in both
tissues (Table S2 and Table S3) and these occurred in 10
participants. Five of these people were in the .70 year age group,
Figure 1. Analysis of mitochondrial DNA point mutation frequency with age by Random Mutation Capture (RMC). (A) Schematic
diagram describing the RMC methodology. (i) Schematic diagram of the structure of the human colorectal crypt. (ii) Schematic diagram showing
mtDNA isolation. Colonoscopic biopsies are homogenized and the mitochondrial fraction isolated by differential centrifugation. MtDNA is then
prepared by phenol/chloroform extraction and quantified using real-time PCR (standard curve method). (iii) MtDNA is digested for 10 hours with
Taq1a. PCR is then carried out over the restriction site. Only molecules with mutations in the restriction site are able to successfully amplify. (iv)
Agarose gel showing PCR products from a typical RMC run. Each reaction contained ,10000 target base pairs. 488 base pair bands show amplified
mutated molecules (wells 4,6,13,16 and 20). The wild-type control well (Wt) shows complete digestion of wild-type DNA following PCR. (v) Example
electropherograms showing mutations (asterisks) within the restriction site (highlighted in blue). (B) Frequency of all RMC detected mtDNA
mutations in human colorectal mucosa (n = 207). There was no correlation between mtDNA mutation frequency and age (Pearson correlation = 0.127
(P = 0.07)). (C) Data from (B) presented on a log 10 scale to show the spread of the data. Note that the zero values cannot be displayed in this way
therefore n= 175. (D) Frequency of all mtDNA mutations detected in human colonic mucosa, grouped by decade. Subjects were grouped as follows,
17–26 (n = 12), 27–36 (n = 19), 37–46 (n = 58), 47–56 (n = 51), 57–66 (n = 43), 67–77 (n = 23). There were no significant differences between any of the
groups (P = 0.343, One Way ANOVA).
doi:10.1371/journal.pgen.1004620.g001
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five were in the ,26 year age group. There was no significant
difference in the frequency of germline or embryological mtDNA
mutations between the ,26 year and .70 year age group
(p = 0.176, unpaired t-test) confirming that there was no age-effect
and that these mtDNA mutations were most likely of germline or
embryological origin.
The frequency of somatic mtDNA mutations in the colon
samples was then analysed by subtracting the germline or
embryological mtDNA mutations from the total mtDNA mutation
frequency. This revealed a significant 10-fold increase in the
frequency of clonally expanded somatic mtDNA mutations in
those aged .70 years compared with ,26 years (Figure 4A,
p= 0.035, unpaired t-test). From here on the mtDNA mutations
detected in colorectal epithelium only will be referred to as somatic
mtDNA mutations and those present in both buccal and colorectal
epithelium as germline or early embryological mtDNA mutations.
The pattern of somatic mtDNA mutations detected in the buccal
epithelium was similar to those in the colonic epithelium. The
mtDNA mutations detected were base transitions and were
randomly located throughout the genome. We did observe a
higher number of somatic mtDNA mutations in the colonic
epithelial samples compared to the buccal samples. We have
previously shown that there are tissue specific differences in the
frequency of clonally expanded mtDNA mutations, with the colon
being one of the most highly affected [10] and believe that this
could explain these differences.
Next we compared the ratio of synonymous or polymorphic
protein encoding mtDNA mutations to non-synonymous mtDNA
mutations in the somatic and germline or early embryological data
sets to see if there were any differences between the two, and
therefore any evidence for purifying selection. There was a
significantly higher proportion of non-synonymous mtDNA
mutations in the somatic data set compared with the germline
or early embryological data set (Fisher’s exact test with, p = 0.041,
Figure 4B); in fact only one of the germline or early embryological
mtDNA mutations was non-synonymous and therefore potentially
pathogenic. These data suggest that the mtDNA mutations likely
to contribute to the mitochondrial ageing phenotype begin to
occur sometime after 3–4 weeks gestation (1–2 weeks post-
conception), which coincides with the resumption of mtDNA
replication which is thought to occur post-embryo implantation
[33].
A significant increase in the frequency of respiratory
chain deficient colonic crypts with age correlates with
the frequency of mutations detected by NGS
We have previously shown that the frequency of crypts deficient
in cytochrome c oxidase activity (complex IV of the respiratory
Figure 2. Schematic diagram showing the detection limits of each of the techniques utilised in this study.
doi:10.1371/journal.pgen.1004620.g002
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chain) increases with age in the apparently normal mucosa taken
from patients with a colorectal tumour [5]. We also demonstrated
that in the vast majority of these crypts there is an intracellular
clonally expanded mtDNA point mutation [5,34]. The present
study provided an opportunity to determine whether there was a
similar age-related increase in the frequency of crypts deficient in
cytochrome c oxidase activity in healthy participants in whom
there was no evidence of mucosal dysplasia. In addition, as
cytochrome c oxidase (COX)/succinate dehydrogenase (SDH)
histochemistry is an excellent surrogate marker for mid-high level
intracellular clonally expanded mtDNA point mutations, which
both RMC and NGS are quite likely to miss, this assay gives an
indication of the frequency of such mutations (Figure 2).
Colorectal mucosal biopsies collected by endoscopy from the
same 207 subjects investigated by the RMC assay were subjected
to sequential COX/SDH histochemistry (Figure 5A) and the
percentage of COX deficient colonic crypts calculated. As
expected, there was a significant increase in the percentage of
COX deficient crypts in individuals with age (Figure 5B, Pearson
correlation 0.603 (p,0.001)). The somatic mtDNA mutations
detected using the Ion Torrent NGS platform could be clonally
expanded mtDNA mutations in individual colonic crypts or low
level clonally expanded mtDNA mutations present throughout the
whole tissue. Therefore we investigated a possible correlation
between the percentage of COX deficient crypts (known to be a
good marker of clonally expanded mtDNA point mutations [5])
and the somatic mtDNA mutation frequency measured by NGS.
This showed that there was a significant correlation between
mtDNA mutation frequency as measured by NGS and COX
deficient crypts (Figure 5C, Pearson correlation= 0.511
(p = 0.043)). When we compared the germline mtDNA mutation
frequency with the percentage of COX deficient crypts, there was
no significant correlation (Figure 5D, Pearson correlation = 0.369,
p = 0.176). There was no significant correlation between the
Figure 4. Exclusion of mitochondrial DNA (mtDNA) mutations occurring in the germline or in early embryogenesis. (A) Somatic
mtDNA frequency (mtDNA mutations present in colon only) measured by NGS. There was a significantly higher mutation frequency in the subjects.
70 years (P = 0.0351, unpaired t-test). (B) Percentage of synonymous/polymorphic variants and non-synonymous mtDNA mutations which were of
germline or early embryological origin compared to those which were somatic in adults ,26 years of age and over 70 years of age. There was a
significantly lower frequency of non-synonymous mtDNA mutations in the somatic mtDNA mutation groups compared to the germline or early
embryological mtDNA mutation group (p = 0.041 Fisher’s, exact test).
doi:10.1371/journal.pgen.1004620.g004
Figure 3. Mitochondrial DNA mutations in human colorectal epithelium of subjects below 26 years of age (n=8) and over 70 years
of age (n=8) measured by Next Generation Sequencing (NGS). (A) MtDNA mutation frequency. There was a significantly higher mutation
frequency in the subjects .70 years (p = 0.0361, unpaired t-test). (B) Types of mutations detected by NGS frequency. There was no significant
difference in the types of mutations detected in subjects ,26 and .70 years of age (p = 1.00, Fisher’s exact test).
doi:10.1371/journal.pgen.1004620.g003
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Figure 5. Quantification of mitochondrial dysfunction in human colonic crypts by cytochrome c oxidase (COX)/succinate
dehydrogenase (SDH) histochemistry. (A) COX/SDH sequential histochemistry on a transverse section of human colorectal mucosa. The crypts
which stain brown have functional COX and SDH activity; those which are blue have lost COX activity but retain SDH activity. (i) shows an image from
a subject aged 25 in whom no COX deficient crypts were detected. (ii) shows an image from a subject aged 72 in whom 28% of crypts were COX
deficient (B) COX activity was measured in colorectal biopsies from 207 subjects. A crypt was defined as deficient if more than 50% of cells had lost
COX activity. There was a significant correlation between age and the percentage of COX deficient crypts. (Pearson correlation = 0.603, p,0.0001). (C)
Correlation analysis between somatic mtDNA mutation frequency determined by NGS and percentage COX deficient crypts showed a significant
correlation (Pearson correlation = 0.511, p = 0.043). (D) Correlation analysis between germline mtDNA mutation frequency determined by NGS and
percentage COX deficient crypts showed no significant correlation (Pearson correlation= 0.369, p = 0.176). (E) Correlation analysis between the
frequency of random mtDNA mutations by RMC and percentage COX deficient crypts showed no significant correlation (Pearson correlation = 0.007,
p = 0.918). (F) Correlation analysis between the frequency of random mtDNA mutations by RMC and those by NGS in paired samples showed no
significant correlation (Pearson correlation= 0.145, p = 0.381).
doi:10.1371/journal.pgen.1004620.g005
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mtDNA mutation frequency detected by RMC and COX
deficiency (Figure 5E, Pearson correlation= 0.007, p = 0.918),
suggesting that the majority of pathogenic mtDNA mutations
detected by NGS are somatic clonally expanded variants. In
addition when we compared the RMC and NGS data from the
same subjects side by side, there was no significant correlation
confirming that the two assays were measuring different classes of
mtDNA mutations i.e. low level vs clonally expanded (Figure 5F,
Pearson correlation= 0.381, p= 0.145, Figure 2).
Discussion
In this study we have examined the timing of occurrence and
frequency of mtDNA mutations during ageing in human
colorectal epithelium. We have employed a range of methodol-
ogies to provide accurate assessment of low level mtDNA mutation
frequency, germline mtDNA heteroplasmy, and both high and low
level intracellular clonal expansion. For low level mtDNA
mutation frequency, we have shown previously that the most
accurate method to use is the RMC assay [25], which provides the
best available measure of mtDNA mutation rate [23]. An
advantage of this assay is that it is not affected by false positive
mutational calls caused by either PCR or sequencing errors;
however a limitation is that, because only a small mtDNA domain
is interrogated, it will miss the majority if not all intracellular
clonally expanded mtDNA mutations. The NGS approach we
have used is, in our hands, sensitive down to 0.8% heteroplasmy
which correlates to either low-level germline mtDNA hetero-
plasmy or homoplasmic intracellular mtDNA clonal expansions in
one or more crypts [14] (based on there being ,200 crypts in a
colonoscopic biopsy sample). Sequencing of individual laser micro-
dissected crypts, which we have done extensively in our previous
work [5,34], is required to detect the remaining mtDNA
mutations, i.e. mid-high level intracellular clonal expansions; these
can also be detected using COX/SDH histochemistry as a
surrogate marker [5,14,34,35] as we have done here (Figure 2).
There is the possibility that there are effectors of COX deficiency
other than clonally expanded mtDNA point mutations, such as
nuclear DNA mutations or changes in global gene expression;
however we have previously found evidence of a clonally
expanded mtDNA point mutation in .75% of crypts sequenced
[5,14,34,35] and therefore believe that this is an excellent
surrogate marker. We have not previously detected any large-
scale mtDNA deletions in individual COX deficient crypts [5].
The RMC assay revealed that there was no significant increase
in low level mtDNA mutation frequency with age. This is
supported by a published study which used RMC to measure
mtDNA mutation frequency in colonic epithelium from a much
smaller cohort of individuals covering a narrower age range (,50–
90 years of age (n = 20)) [23]. An important result of our study is a
demonstration that the lack of an increase in low level RMC-
detected mtDNA mutations (i.e. no increase in mtDNA mutation
rate) does not mean that there is no increase in total mtDNA
mutation load with age. Instead, we show that clonally expanded
mutations, as measured by NGS, increase very dramatically. This
is the first demonstration that mtDNA mutation rate and clonal
expansion may follow very different age dynamics. This is in direct
contradiction of the mitochondrial vicious cycle hypothesis of
ageing [36] which suggests that mtDNA mutations occur during
ageing leading to dysfunctional proteins in the oxidative
phosphorylation system, precipitating increased mutation i.e. an
accelerating mtDNA mutation rate over time. Our results also
demonstrate that caution should be exercised in interpreting
mutation analysis results, which may be limited to only a portion
of mutations depending on the technique used.
Together the NGS and RMC datasets suggest that mtDNA
mutation rate does not change significantly with age, but that
clonal expansion of mtDNA mutations occurs over time.
Mathematical modelling studies have suggested that clonal
expansion of mtDNA mutations within an individual cell is likely
to be due to random genetic drift and predict that it can take at
least 20 years for an mtDNA mutation to clonally expand to high
levels sufficient to cause COX deficiency [37–39]. Indeed, the
youngest participant in this cohort in whom COX deficiency was
detected was 21 years of age, therefore the initial mutational
event(s) in this case must have occurred very early in life.
Interestingly, the mtDNA mutation frequency data by NGS from
our human samples were different to those obtained from a similar
NGS study carried out in mice in which no significant increase in
mtDNA mutation frequency with age was noted [40]. Previously
we examined colonic epithelial tissue from a similar ageing mouse
colony and showed that clonal expansion of mtDNA mutations
was a very rare event in these animals compared with aged
humans [41]. This may explain the species differences in these
data, consistent with modelling studies that emphasise the
difficulty of generating clonal expansion through random drift in
short-lived animals [39].
Whilst our data imply that mutations of very early origin
contribute to mitochondrial dysfunction in old age, it does not
mean that mutations occurring in adult life play no role. In fact,
the number of different clonally expanded mutations per sample
detected by NGS robustly increased with age (3-fold from ,26
years to .70 years group, p = 0.001). Such an increase in mtDNA
point mutation diversity can be explained with a scenario whereby
de novo mtDNA point mutations occurring during adult life,
perhaps up to middle-age, are able to clonally expand and join the
set of expanded mutations detected in old age. However mtDNA
mutations which occur late in life will not have time to expand to
high levels.
Analysis of the RMC data showed that even in the youngest
participants, we observed a substantial load of mtDNA mutations
in the colonic epithelium. NGS analysis of a subset of our youngest
participants, all of whom were ,26 years of age (n = 8), confirmed
the RMC data; young adults have a significant mtDNA point
mutation load. This has been previously shown to be the case in
DNA extracted from young brain [42,43], where both point
mutations and mtDNA deletions have been detected. Our RMC
data have now shown that this is also the case for a mitotic tissue,
the colonic epithelium. In addition we have clearly demonstrated
that the same type of mtDNA mutations (point mutations which
are predominantly transitions) are present in young individuals as
those detected in our previous studies of clonally expanded
mtDNA mutations from aged respiratory chain deficient individ-
ual crypts [34], i.e. the seed mutations for clonal expansion can be
laid down at an early age. Although this has been predicted by
modelling simulations [37,38] this is the first experimental
evidence to show this definitively.
Our NGS analysis has shown that low level heteroplasmic
mutations are present in multiple tissues from the same individual.
This supports previous studies showing that mtDNA mutations in
adult tissues can originate in germline or very early development
[27,28]. Indeed, our data from the colonic and buccal epithelium
show that mtDNA mutations present in both tissues must have
occurred prior to the fore and hind guts becoming separate which
is thought to occur 1–2 weeks post-conception [32]. It is possible
that due to our conservative cut off of 0.8% heteroplasmy, there
may be additional germline mtDNA mutations which have
Clonal Expansion of Early-Life mtDNA Mutations in Ageing Human Colon
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undergone less drastic clonal expansion in one of the two tissues
studied than the other, and therefore are below the threshold of
detection; this is one of the limitations of the available technology.
These data do show that 95% of the heteroplasmic mutations
detected in both tissues were non-pathogenic polymorphic
variants, thus suggesting that pathogenic mtDNA mutations which
occur in the germline or early development are selected against,
and these non-pathogenic mtDNA mutations may make little
contribution to the ageing phenotype. This demonstrates purifying
selection in the human germline. Previous studies have shown this
in mice by looking at transmission of mtDNA mutations through
multiple generations [44,45]; here we show purifying selection in
humans by comparing the germline and somatic mtDNA
mutations in different tissues from the same subjects. Recent
evidence from the mouse has suggested that transmitted germline
mtDNA mutations can cause premature ageing, perhaps by clonal
expansion of these germline mtDNA mutations over time [46]. In
our dataset 95% of the germline mtDNA mutations are benign
and are unlikely to cause mitochondrial dysfunction and
premature ageing, suggesting that there are differences in the
dynamics of mtDNA transmission between these mutation prone
mice and humans.
The somatic mtDNA mutations detected by NGS in the colonic
epithelium only, are a combination of benign synonymous and
polymorphic variants and non-synonymous potentially pathogenic
variants, which we believe may begin to occur when mtDNA
replication is re-initiated after the embryo has implanted into the
uterine wall [33]. There was a significantly higher frequency of
non-synonymous coding region somatic mtDNA mutations
compared to the germline or early embryological mtDNA
mutations which is evidence in support of the hypothesis that
the somatic mutations occurred beyond any selective checkpoints,
before expanding clonally to detectable levels.
The observations in this study are in agreement with evidence
from epidemiological studies which suggest that damage arising
early in human life can be an important modulator of outcomes in
later life [47,48]. Due to the time taken for clonal expansion of
mtDNA mutations to occur in human cells, we hypothesise that
late life de novo mtDNA mutational events make negligible
contribution to the ageing phenotype and that early to mid-life
mtDNA mutations are likely to be much more important.
Materials and Methods
Participants
Colorectal mucosal samples were collected from the same
anatomical site (10 cm from the anal verge) from participants
(n = 207, age range 17–78 years) undergoing colonoscopy for
disturbed bowel function in whom no evidence of bowel disease
was identified (BORICC 1 Study). Buccal epithelial scrapes were
also collected concurrently from these subjects. The following
subjects were also used in our previous work: BCC010, BCC011,
BCC017, BCC022, BCC028, BCC085, BCC087, BCC088 [25].
Ethics statement
Ethical approval was obtained from the Northumbria NHS
Trust Local Research Ethics Committee (Project reference
NLREC2/2001). All participants were fully informed and written
consent obtained from them.
Random Mutation Capture (RMC)
RMC was carried out essentially as previously described [25].
Briefly, mtDNA was extracted from colorectal mucosal biopsies
and drop-dialysed using membrane filters (0.025 mm, Millipore) to
extract any excess salts. One microlitre of mtDNA was digested
with 100 U of TaqIa (New England Biolabs) for 10 hours with the
addition of 100 U every hour. MtDNA copy number was
quantified by SYBR Green real-time PCR (Roche) targeting a
template outside of a TaqIa restriction site in MTND5 (primers
L12473–L12492 and H12573-H12554) Absolute quantification
was carried out using the standard curve method. PCR was then
carried out across a TaqIa restriction site within the MTCOI gene
(bp 6562–6565, primers L4636–L6455 and H6851–H6870). An
average of 2500 copies of the target sequence (a total of 10000
target bases) was added to each PCR reaction. Following PCR
each product was digested with 50 units of TaqIa for 1 hour at
65uC, followed by 10 minutes at 80uC to inactivate the enzyme.
Products were then subjected to electrophoresis through a 1.5%
agarose gel for 1 hour at 200 V. All full length (488 bp) products
were excised from the gel using a QIAquick Gel Extraction kit
(Qiagen). These products were sequenced using ABI BigDye
chemistries per standard manufacturer’s protocols and analysed on
an ABI3100 Genetic Analyser (Applied Biosystems). Sequences
obtained were compared with the revised Cambridge Reference
Sequence (GenBank accession number: NC_012920.1) using
SeqScape software (Applied Biosystems). Mutation load was
calculated by dividing the number of confirmed mutants by the
total number of base pairs investigated.
Validation of the RMC assay
To investigate the sensitivity and specificity of the RMC assay in
our hands we generated a PCR product which contained a
mtDNA mutation in the RMC site and one which was wild-type in
the RMC site. A pCR-scriptTM Amp SK(+) cloning Kit
(Stratagene) was used to clone the products following the
manufacturer’s protocol. Recombinant plasmids were identified
by blue–white colour selection and the cultures grown up using a
Qiaquick miniprep kit (Qiagen). The DNA was then extracted and
quantified and the wild-type and mutant PCR products mixed at
concentrations ranging from 100% wild-type to 100% mutant.
The RMC assay was then carried out as above and the observed
mutant fractions calculated and compared to the expected
fractions (Table S4). There was no difference between observed
and expected fractions, confirming the RMC assay to be both
highly sensitive and specific.
Next generation sequencing
Next generation sequencing (NGS) was carried out using an Ion
Torrent Personal Genome Machine (Life Technologies, Paisley,
UK) on whole mtDNA from the same colonic biopsies investigated
by RMC and from buccal epithelia from the 8 youngest (,26
years) and 8 oldest (.70 years) subjects. To exclude the possibility
of nuclear pseudogene amplification, extracted DNA was ampli-
fied in two overlapping 9 kb fragments using primers L2091–
L2111 and H10649-H10629 (primer set 1), and L10085–L10104
and H2644-2625 (primer set 2), the specificity of which was
established after observing no amplification from Rho Zero cells,
cells depleted of their mtDNA by ethidium bromide treatment.
Long-range PCR amplicons were quantified on an Agilent 2100
Bioanalyzer with an Agilent DNA 12,000 kit (Agilent Technolo-
gies, Stockport, UK). Overlapping PCR fragments for each sample
were combined in equimolar concentrations. Pooled amplicons
(100 ng) were then fragmented, barcoded, size-selected and
amplified using the IonXpress Plus Fragment Library kit, Ion
Xpress Barcode Adapters and E-Gel SizeSelect 2% agarose gels
(Life Technologies), according to the manufacturer’s recommen-
dations. Barcoded libraries were quantified with an Agilent
Bioanalyzer DNA High Sensitivity kit then pooled (n= 16) in
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equimolar concentrations and diluted to 26 pM, prior to clonal
amplification onto Ion Sphere Particles using the Ion OneTouch 1
System and the Ion OneTouch 200 Template kit v2 (Life
Technologies), as per the manufacturer’s instructions. Coated
spheres were enriched on the Ion Torrent ES (Life Technologies)
before loading onto Ion 318 sequencing chips (Life Technologies).
Next-generation semiconductor sequencing was performed on an
Ion Torrent Personal Genome Machine (Life Technologies). Fastq
data files downloaded from the Torrent Server (version 3.6.2, Life
Technologies) were analysed using NextGENe software (v2.3.0;
SoftGenetics, State College, PA, USA).
Quality control criteria for NGS
The background noise on the Ion Torrent PGM platform was
quantified by extraction of DNA from a yeast clone which had
been transfected with a plasmid (pRShmt) containing the entire
human mtDNA [49] (kindly donated by Dr Brian Bigger
(University of Manchester, UK)) which was then subjected to an
identical PCR amplification and NGS protocol as the colonic
biopsy and buccal scrape samples. On this basis any low level
mtDNA variants detected in the cloned mtDNA are likely to be
technical artefacts arising from the PCR and sequencing process
and we could quantify the level of background noise and exclude
this from the sample analysis. In addition the Ion Torrent platform
may be prone to base calling errors in polynucleotide tracts, most
often calling them as small insertions or deletions; therefore we
restricted the analysis to base-pair substitutions only. Further
quality control steps taken were; (1) only base substitutions with a
quality score .20 were included in order to be confident that the
calls were genuine, (2) observed variants had to be present in both
forward and reverse reads at comparable frequencies with a 3-fold
difference permitted to allow for the effects of a binomial sampling
distribution at very low variant levels [28], (3) at least 3 reads were
required for each variant, with a minimum total coverage of 600
reads per site. There was an unstable tract between base pairs
3902 and 3908 which repeatedly showed heteroplasmy levels
between 1% and 5% in all of the samples and the plasmid control,
as did a recognised variant at base pair 750. These mtDNA
variants were deemed artefactual and removed from the analysis.
Using these stringent criteria, there were no variants present at
.0.65% in the cloned DNA template (Table S5). We took a
conservative approach and only recorded mutations present at
.0.8%. This approach ensured that any variants detected in the
samples at levels of .0.8% are likely to be generated in vivo and
be of biological origin. The published base-substitution error rate
for mtDNA on the Ion Torrent PGM is 0.12% [50].
Cyctochrome c oxidase/succinate dehydrogenase (COX/
SDH) histochemistry
Colon samples were mounted for sectioning and frozen in
isopentane previously cooled to 2190uC in liquid nitrogen.
Cryostat sections (12 mm) were cut onto glass slides and incubated
in COX medium (100 mM cytochrome c, 4 mM diaminobenzi-
dine tetrahydrochloride and 20 mg.ml21 catalase in 0.2 M
phosphate buffer pH 7.0) at 37uC for 50 minutes. Sections were
washed in phosphate buffered saline, pH 7.4 (365 minutes) and
incubated in SDH medium (130 mM sodium succinate, 200 mM
phenazine methosulphate, 1 mM sodium azide, 1.5 mM nitroblue
tetrazolium in 0.2 M phosphate buffer pH 7.0) at 37uC for
45 minutes. Finally, sections were washed in phosphate buffered
saline, pH 7.4 (365 minutes), dehydrated in a graded ethanol
series (70%, 95%, 26100%), cleared in Histoclear (National
Diagnostics, Atlanta, USA) and mounted in DPX.
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